Business
0
Intellia stock tumbles on safety concerns - Yahoo Finance
Investing.com -- Shares of Intellia Therapeutics (NASDAQ: NASDAQ:NTLA) plunged 19% following a safety update from its ongoing Phase 3 MAGNITUDE study. The...
Comments